Sheetal Hardikar

Sheetal Hardikar, MPH, PhD, MBBS

Languages spoken: English, Hindi, Marathi

Academic Information

Departments Primary - Population Health Sciences

Research Interests

  • Identifying and Evaluating Novel Molecular and Genetic Biomarkers for Cancer Risk and Prognosis of Gastrointestinal Cancers
  • The Role of Inflammation in Development, Prevention, and Progression of Gastrointestinal Cancers
  • Chronic Conditions Related to Inflammation, Including Obesity and Diabetes, and Their Role in the Development and Progression of Gastrointestinal Cancers
  • Cancer Screening Through Risk Stratification

Education History

Research Fellow Fred Hutchinson Cancer Center
 Postdoctoral Fellow
University of Washington School of Public Health
 PhD
Graduate Training Ohio State University College of Public Health
 MPH
Ohio State University College of Public Health
 MS
Professional Medical Maharashtra University of Health Sciences/TN Medical College & BYL Nair Charitable Hospital
 MBBS

Selected Publications

Journal Article

  1. Alexander A, Brown N, Horns JJ, Hardikar S, Playdon M, Das R, Driggs N, Paudel N, Matsen C, Ibele A (2024). Screening Mammography Adherence Improves After Bariatric Surgery. J Surg Res, 303, 476-481. (Read full article)
  2. Mahamat-Saleh Y, Aune D, Freisling H, Hardikar S, Jaafar R, Rinaldi S, Gunter MJ, Dossus L (2024). Association of metabolic obesity phenotypes with risk of overall and site-specific cancers: a systematic review and meta-analysis of cohort studies. Br J Cancer. (Read full article)
  3. Dravillas CE, Coleman SS 4th, Hoyd R, Caryotakis G, Denko L, Chan CHF, Churchman ML, Denko N, Dodd RD, Eljilany I, Hardikar S, Husain M, Ikeguchi AP, Jin N, Ma Q, McCarter MD, Osman AEG, Robinson LA, Singer EA, Tinoco G, Ulrich CM, Zakharia Y, Spakowicz D, Tarhini AA, Tan AC, exORIEN Consortium (2023). The Tumor Microbiome as a Predictor of Outcomes in Patients with Metastatic Melanoma Treated with Immune Checkpoint Inhibitors. Cancer Res Commun, 4(8), 1978-1990. (Read full article)
  4. Benej M, Hoyd R, Kreamer M, Wheeler CE, Grencewicz DJ, Choueiry F, Chan CHF, Zakharia Y, Ma Q, Dodd RD, Ulrich CM, Hardikar S, Churchman ML, Tarhini AA, Robinson LA, Singer EA, Ikeguchi AP, McCarter MD, Tinoco G, Husain M, Jin N, Tan AC, Osman AEG, Eljilany I, Riedlinger G, Schneider BP, Benejova K, Kery M, Papandreou I, Zhu J, Denko N, Spakowicz D, exORIEN Consortium (2023). The Tumor Microbiome Reacts to Hypoxia and Can Influence Response to Radiation Treatment in Colorectal Cancer. Cancer Res Commun, 4(7), 1690-1701. (Read full article)
  5. Oswald LB, Bloomer A, Li X, Jean-Baptiste E, Trujillo G, Felder S, Small BJ, Ose J, Hardikar S, Strehli I, Huang LC, Mooney K, Mutch MG, Chao D, Cohen SA, Karchi M, Wood EH, Damerell V, Loroa NC, Gong J, Toriola AT, Li CI, Shibata D, Schneider M, Gigic B, Figueiredo JC, Jim HSL, Ulrich CM, Siegel EM (2024). Functional quality of life among newly diagnosed young adult colorectal cancer survivors compared to older adults: results from the ColoCare Study. Support Care Cancer, 32(5), 298. (Read full article)
  6. Amann ES, Ose J, Hathaway CA, Oswald LB, Hardikar S, Himbert C, Chellam V, Lin T, Daniels B, Kirchhoff AC, Gigic B, Grossman D, Tward J, Varghese TK Jr, Shibata D, Figueiredo JC, Toriola AT, Beck A, Scaife C, Barnes CA, Matsen C, Ma DS, Colman H, Hunt JP, Jones KB, Lee CJ, Larson M, Onega T, Akerley WL, Li CI, Grady WM, Schneider M, Dinkel A, Islam JY, Gonzalez BD, Otto AK, Penedo FJ, Siegel EM, Tworoger SS, Ulrich CM, Peoples AR (2024). Risk factors and health behaviors associated with loneliness among cancer survivors during the COVID-19 pandemic. J Behav Med, 47(3), 405-421. (Read full article)
  7. Wang C, Ma A, Li Y, McNutt ME, Zhang S, Zhu J, Hoyd R, Wheeler CE, Robinson LA, Chan CHF, Zakharia Y, Dodd RD, Ulrich CM, Hardikar S, Churchman ML, Tarhini AA, Singer EA, Ikeguchi AP, McCarter MD, Denko N, Tinoco G, Husain M, Jin N, Osman AEG, Eljilany I, Tan AC, Coleman SS, Denko L, Riedlinger G, Schneider BP, Spakowicz D, Ma Q (2024). A bioinformatics tool for identifying intratumoral microbes from the ORIEN dataset. Cancer Res Commun, 4(2), 293-302. (Read full article)
  8. Crowder SL, Li X, Himbert C, Viskochil R, Hoogland AI, Gudenkauf LM, Oswald LB, Gonzalez BD, Small BJ, Ulrich CM, Ose J, Peoples AR, Li CI, Shibata D, Toriola AT, Gigic B, Playdon MC, Hardikar S, Bower J, Siegel EM, Figueiredo JC, Jim HSL (2023). Relationships Among Physical Activity, Sleep, and Cancer-related Fatigue: Results From the International ColoCare Study. Ann Behav Med, 58(3), 156-166. (Read full article)
  9. Adams TD, Meeks H, Fraser A, Davidson LE, Holmen J, Newman M, Ibele AR, Playdon M, Hardikar S, Richards N, Hunt SC, Kim J (2023). Long-term cancer outcomes after bariatric surgery. Obesity (Silver Spring), 31(9), 2386-2397. (Read full article)
  10. Marsiglio J, McPherson JP, Kovacsovics-Bankowski M, Jeter J, Vaklavas C, Swami U, Grossmann D, Erickson-Wayman A, Soares HP, Kerrigan K, Gibson B, Doherty JA, Hyngstrom J, Hardikar S, Hu-Lieskovan S (2023). A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome. Front Immunol, 14, 1229823. (Read full article)
  11. Karra P, Hardikar S, Winn M, Anderson GL, Haaland B, Krick B, Thomson CA, Shadyab A, Luo J, Saquib N, Strickler HD, Chlebowski R, Arthur RS, Summers SA, Holland WL, Jalili T, Playdon MC (2023). New-onset diabetes after an obesity-related cancer diagnosis and survival outcomes in the Women's Health Initiative. Cancer Epidemiol Biomarkers Prev. (Read full article)
  12. Winn M, Karra P, Freisling H, Gunter MJ, Haaland B, Litchman ML, Doherty JA, Playdon MC, Hardikar S (2023). Metabolic obesity phenotypes and obesity-related cancer risk in the National Health and Nutrition Examination Survey. Endocrinol Diabetes Metab, 6(4), e433. (Read full article)
  13. Playdon MC, Hardikar S, Karra P, Hoobler R, Ibele AR, Cook KL, Kumar A, Ippolito JE, Brown JC (2022). Metabolic and bariatric surgery and obesity pharmacotherapy for cancer prevention: current status and future possibilities. J Natl Cancer Inst Monogr, 2023(61), 68-76. (Read full article)
  14. Peterson L, Lee H, Huybrechts I, Biessy C, Neuhouser ML, Haaland B, Krick B, Gunter M, Schulze MB, Jannasch F, Coletta AM, Hardikar S, Chaix A, Bauer CX, Xiao Q, Playdon MC (2023). Reliability estimates for assessing meal timing derived from longitudinal repeated 24-hour dietary recalls. Am J Clin Nutr, 117(5), 964-975. (Read full article)
  15. Himbert C, Ose J, Gigic B, Viskochil R, Santuci K, Lin T, Ashworth A, Cohan JN, Scaife CL, Jedrzkiewicz J, Damerell V, Atkins KM, Gong J, Mutch MG, Bernadt C, Felder S, Sanchez J, Cohen SA, Krane MK, Hinkle N, Wood E, Peoples AR, Figueiredo JC, Toriola AT, Siegel EM, Li CI, Shibata D, Boucher K, Round JL, Ulrich AB, Schneider M, Huang LC, Hardikar S, Ulrich CM (2023). Associations of combined physical activity and body mass index groups with colorectal cancer survival outcomes. BMC Cancer, 23(1), 300. (Read full article)
  16. Berghuijs KMVT, Kaddas HK, Trujillo G, Rouhani G, Chevrier A, Ose J, Shibata D, Toriola AT, Figueiredo JC, Peoples AR, Li CI, Hardikar S, Siegel EM, Gigic B, Schneider M, Ulrich CM, Kirchhoff AC (2023). Age-related differences in employment, insurance, and financial hardship among colorectal cancer patients: a report from the ColoCare Study. J Cancer Surviv, 18(3), 1075-1084. (Read full article)
  17. Lindley CL, Gigic B, Peoples AR, Han CJ, Lin T, Himbert C, Warby CA, Boehm J, Hardikar S, Ashworth A, Schneider M, Ulrich A, Schrotz-King P, Figueiredo JC, Li CI, Shibata D, Siegel EM, Toriola AT, Ulrich CM, Syrjala KL, Ose J (2022). Pre-Surgery Inflammatory and Angiogenesis Biomarkers as Predictors of 12-Month Cancer-Related Distress: Results from the ColoCare Study. Cancer Epidemiol Biomarkers Prev, 32(3), 363-370. (Read full article)
  18. Pauleck S, Sinnott JA, Zheng YL, Gadalla SM, Viskochil R, Haaland B, Cawthon RM, Hoffmeister A, Hardikar S (2023). Association of telomere length with colorectal cancer risk and prognosis: A systematic review and meta-analysis. Cancers (Basel), 15(4), 1159. (Read full article)
  19. Benson R, Winterton C, Winn M, Krick B, Liu M, Abu-El-Rub N, Conway M, Del Fiol G, Gawron A, Hardikar S (2024). Leveraging Natural Language Processing to Extract Features of Colorectal Polyps From Pathology Reports for Epidemiologic Study. JCO Clin Cancer Inform, 7, e2200131. (Read full article)
  20. Himbert C, Stephens WZ, Gigic B, Hardikar S, Holowatyj AN, Lin T, Ose J, Swanson E, Ashworth A, Warby CA, Peoples AR, Nix D, Jedrzkiewicz J, Bronner M, Pickron B, Scaife C, Cohan JN, Schrotz-King P, Habermann N, Boehm J, Hullar M, Figueiredo JC, Toriola AT, Siegel EM, Li CI, Ulrich AB, Shibata D, Boucher K, Huang LC, Schneider M, Round JL, Ulrich CM (2022). Differences in the gut microbiome by physical activity and BMI among colorectal cancer patients. Am J Cancer Res, 12(10), 4789-4801. (Read full article)
  21. Himbert C, Warby CA, Gigic B, Ose J, Lin T, Viskochil R, Peoples AR, Ashworth A, Schrotz-King P, Scaife CL, Cohan JN, Jedrzkiewicz J, Schirmacher P, Grady WM, Cohen SA, Krane M, Figueiredo JC, Toriola AT, Siegel EM, Shibata D, Round JL, Huang LC, Li CI, Schneider M, Ulrich A, Hardikar S, Ulrich CM (2022). Associations of individual and combined physical activity and body mass index groups with pro-inflammatory biomarkers among colorectal cancer patients. Cancer Epidemiol Biomarkers Prev, 31(12), 2148-2156. (Read full article)
  22. Karra P, Winn M, Pauleck S, Bulsiewicz-Jacobsen A, Peterson L, Coletta A, Doherty J, Ulrich CM, Summers SA, Gunter M, Hardikar S, Playdon MC (2022). Metabolic dysfunction and obesity-related cancer: Beyond obesity and metabolic syndrome. Obesity (Silver Spring), 30(7), 1323-1334. (Read full article)
  23. Hardikar S, Krick B, Benson R, Winn M, Winterton C, Newcomb PA, Inadomi JM, Ulrich CM (2022). Type-2 Diabetes Mellitus and Risk of Colorectal Polyps: A Colonoscopy-Based Study Using Natural Language Processing. Cancer Epidemiol Biomarkers Prev, 31(7), 1513. (Read full article)
  24. Winn M, Karra P, Haaland B, Doherty JA, Summers SA, Litchman ML, Gunter MJ, Playdon MC, Hardikar S (2022). Metabolic dysfunction and obesity-related cancer: Results from the cross-sectional National Health and Nutrition Examination Survey. Cancer Med. (Read full article)
  25. Ose J, Gigic B, Hardikar S, Lin T, Himbert C, Warby CA, Peoples AR, Lindley CL, Boehm J, Schrotz-King P, Figueiredo JC, Toriola AT, Siegel EM, Li CI, Ulrich A, Schneider M, Shibata D, Ulrich CM (2022). Pre-surgery adhesion molecules and angiogenesis biomarkers are differently associated with outcomes in colon and rectal cancer: Results from the ColoCare Study. Cancer Epidemiol Biomarkers Prev, 31(8), 1650-1660. (Read full article)
  26. Pauleck S, Gigic B, Cawthon RM, Ose J, Peoples AR, Warby CA, Sinnott JA, Lin T, Boehm J, Schrotz-King P, Li CI, Shibata D, Siegel EM, Figueiredo JC, Toriola AT, Schneider M, Ulrich AB, Hoffmeister A, Ulrich CM, Hardikar S (2022). Association of circulating leukocyte telomere length with survival in patients with colorectal cancer. J Geriatr Oncol, 13(4), 480-485. (Read full article)
  27. Yang WY, Izzi B, Bress AP, Thijs L, Citterio L, Wei FF, Salvi E, Delli Carpini S, Manunta P, Cusi D, Hoylaerts MF, Luttun A, Verhamme P, Hardikar S, Nawrot TS, Staessen JA, Zhang ZY (2022). Association of colorectal cancer with genetic and epigenetic variation in PEAR1-A population-based cohort study. PLoS One, 17(4), e0266481. (Read full article)
  28. Eisele Y, Mallea PM, Gigic B, Stephens WZ, Warby CA, Buhrke K, Lin T, Boehm J, Schrotz-King P, Hardikar S, Huang LC, Pickron TB, Scaife CL, Viskochil R, Koelsch T, Peoples AR, Pletneva MA, Bronner M, Schneider M, Ulrich AB, Swanson EA, Toriola AT, Shibata D, Li CI, Siegel EM, Figueiredo J, Janssen KP, Hauner H, Round J, Ulrich CM, Holowatyj AN, Ose J (2021). Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study. Clin Colorectal Cancer, 20(3), e165-e172. (Read full article)
  29. Stewart KL, Gigic B, Himbert C, Warby CA, Ose J, Lin T, Schrotz-King P, Boehm J, Jordan KC, Metos J, Schneider M, Figueiredo JC, Li CI, Shibata D, Siegel E, Toriola AT, Hardikar S, Ulrich CM (2021). Association of Sugar Intake with Inflammation- and Angiogenesis-Related Biomarkers in Newly Diagnosed Colorectal Cancer Patients. Nutr Cancer, 74(5), 1-8. (Read full article)
  30. Himbert C, Figueiredo JC, Shibata D, Ose J, Lin T, Huang LC, Peoples AR, Scaife CL, Pickron B, Lambert L, Cohan JN, Bronner M, Felder S, Sanchez J, Dessureault S, Coppola D, Hoffman DM, Nasseri YF, Decker RW, Zaghiyan K, Murrell ZA, Hendifar A, Gong J, Firoozmand E, Gangi A, Moore BA, Cologne KG, El-Masry MS, Hinkle N, Monroe J, Mutch M, Bernadt C, Chatterjee D, Sinanan M, Cohen SA, Wallin U, Grady WM, Lampe PD, Reddi D, Krane M, Fichera A, Moonka R, Herpel E, Schirmacher P, Kloor M, von Knebel-Doeberitz M, Nattenmueller J, Kauczor HU, Swanson E, Jedrzkiewicz J, Schmit SL, Gigic B, Ulrich AB, Toriola AT, Siegel EM, Li CI, Ulrich CM, Hardikar S (2021). Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of Onset. Cancers (Basel), 13(15). (Read full article)
  31. Viskochil R, Gigic B, Lin T, Skender S, Bhm J, Schrotz-King P, Steindorf K, Owen R, Figueiredo JC, Li CI, Siegel EM, Hardikar S, Shibata D, Toriola AT, Schneider M, Ulrich A, Ulrich CM, Ose J (2020). Associations between physical activity, sedentary behavior, and urinary oxidized guanine in colorectal cancer patients: results from the ColoCare Study. Appl Physiol Nutr Metab, 45(11), 1306-1309. (Read full article)
  32. Yin H, Hardikar S, Lindstroem S, Hsu L, Anderson KE, Banbury BL, Berndt SI, Chan AT, Giovanucci EL, Harrison TA, Joshi AD, Nan H, Potter JD, Sakoda LC, Slattery ML, Schoen RE, White E, Peters U, Newcomb PA (2020). Telomere Maintenance Variants and Survival after Colorectal Cancer: Smoking- and Sex-Specific Associations. Cancer Epidemiol Biomarkers Prev, 29(9), 1817-1824. (Read full article)
  33. Jarvik GP, Wang X, Fontanillas P, Kim E, Chanprasert S, Gordon AS, Bastarache L, Kowdley KV, Harrison T, Rosenthal EA, Stanaway IB, Bzieau S, Weinstein SJ, Newcomb PA, Casey G, Platz EA, Visvanathan K, Le Marchand L, Ulrich CM, Hardikar S, Li CI, van Duijnhoven FJB, Gsur A, Campbell PT, Moreno V, Vodika P, Brenner H, Chang-Claude J, Hoffmeister M, Slattery ML, Gunter MJ, Aglago EK, Castellv-Bel S, Kweon SS, Chan AT, Li L, Zheng W, Bishop DT, Giles GG, Rennert G, Offit K, Keku TO, Woods MO, Hampe J, Van Guelpen B, Gallinger SJ, de la Chapelle A, Hampel H, Berndt SI, Tangen CM, Lindblom A, Wolk A, Burnett-Hartman A, Wu AH, White E, 23andMe Research Team, Gruber SB, Jenkins MA, Mountain J, Peters U, Crosslin DR (2020). Hemochromatosis risk genotype is not associated with colorectal cancer or age at its diagnosis. HGG Adv, 1(1), 100010. (Read full article)
  34. Hua X, Newcomb PA, Chubak J, Malen RC, Ziebell R, Kamineni A, Zhu LC, Upton MP, Wurscher MA, Thomas SS, Newman H, Hardikar S, Burnett-Hartman AN (2020). Associations between molecular characteristics of colorectal serrated polyps and subsequent advanced colorectal neoplasia. Cancer Causes Control, 31(7), 631-640. (Read full article)
  35. Kiblawi R, Holowatyj AN, Gigic B, Brezina S, Geijsen AJMR, Ose J, Lin T, Hardikar S, Himbert C, Warby CA, Bhm J, Bours MJL, van Duijnhoven FJB, Gumpenberger T, Kok DE, Koole JL, van Roekel EH, Schrotz-King P, Ulvik A, Gsur A, Habermann N, Weijenberg MP, Ueland PM, Schneider M, Ulrich A, Ulrich CM, Playdon M (2020). One-carbon metabolites, B vitamins and associations with systemic inflammation and angiogenesis biomarkers among colorectal cancer patients: results from the ColoCare Study. Br J Nutr, 123(10), 1187-1200. (Read full article)
  36. Hardikar S, Albrechtsen RD, Achaintre D, Lin T, Pauleck S, Playdon M, Holowatyj AN, Gigic B, Schrotz-King P, Boehm J, Habermann N, Brezina S, Gsur A, van Roekel EH, Weijenberg MP, Keski-Rahkonen P, Scalbert A, Ose J, Ulrich CM (2020). Impact of Pre-blood Collection Factors on Plasma Metabolomic Profiles. Metabolites, 10(5). (Read full article)
  37. Holowatyj AN, Gigic B, Herpel E, Scalbert A, Schneider M, Ulrich CM, MetaboCCC Consortium, ColoCare Study (2020). Distinct Molecular Phenotype of Sporadic Colorectal Cancers Among Young Patients Based on Multi-omics Analysis. Gastroenterology, 158(4), 1155-1158.
  38. Petrick JL, Li N, Anderson LA, Bernstein L, Corley DA, El Serag HB, Hardikar S, Liao LM, Liu G, Murray LJ, Rubenstein JH, Schneider JL, Shaheen NJ, Thrift AP, van den Brandt PA, Vaughan TL, Whiteman DC, Wu AH, Zhao WK, Gammon MD, Cook MB (2019). Diabetes in relation to Barrett's esophagus and adenocarcinomas of the esophagus: A pooled study from the International Barrett's and Esophageal Adenocarcinoma Consortium. Cancer, 125(23), 4210-4223. (Read full article)
  39. Dashti SG, Li WY, Buchanan DD, Clendenning M, Rosty C, Winship IM, Macrae FA, Giles GG, Hardikar S, Hua X, Thibodeau SN, Figueiredo JC, Casey G, Haile RW, Gallinger S, Le Marchand L, Newcomb PA, Potter JD, Lindor NM, Hopper JL, Jenkins MA, Win AK (2019). Type 2 diabetes mellitus, blood cholesterol, triglyceride and colorectal cancer risk in Lynch syndrome. Br J Cancer, 121(10), 869-876. (Read full article)
  40. Ose J, Gigic B, Lin T, Liesenfeld DB, Bhm J, Nattenmller J, Scherer D, Zielske L, Schrotz-King P, Habermann N, Ochs-Balcom HM, Peoples AR, Hardikar S, Li CI, Shibata D, Figueiredo J, Toriola AT, Siegel EM, Schmit S, Schneider M, Ulrich A, Kauczor HU, Ulrich CM (2019). Multiplatform Urinary Metabolomics Profiling to Discriminate Cachectic from Non-Cachectic Colorectal Cancer Patients: Pilot Results from the ColoCare Study. Metabolites, 9(9). (Read full article)
  41. Burnett-Hartman AN, Chubak J, Hua X, Ziebell R, Kamineni A, Zhu LC, Upton MP, Malen RC, Hardikar S, Newcomb PA (2019). The association between colorectal sessile serrated adenomas/polyps and subsequent advanced colorectal neoplasia. Cancer Causes Control, 30(9), 979-987. (Read full article)
  42. Holowatyj AN, Lewis MA, Pannier ST, Kirchhoff AC, Hardikar S, Figueiredo JC, Huang LC, Shibata D, Schmit SL, Ulrich CM (2019). Clinicopathologic and Racial/Ethnic Differences of Colorectal Cancer Among Adolescents and Young Adults. Clin Transl Gastroenterol, 10(7), e00059. (Read full article)
  43. Himbert C, Ose J, Nattenmuller J, Warby C, Bohm J, Lin T, Holowatyj A, Haffa M, Gigic B, Hardikar S, Scherer D, Zielske L, Schrotz-King P, Kolsch T, Siegel E, Shibata D, Ulrich A, Schneider M, Hursting SD, Kauczor H, Ulrich CM (2019). Body fatness, adipose tissue compartments and biomarkers of inflammation and angiogenesis in colorectal cancer; the ColoCare Study. Cancer Epidemiol Biomarkers Prev, 28(1), 76-82.
  44. Dashti SG, Win AK, Hardikar SS, Glombicki SE, Mallenahalli S, Thirumurthi S, Peterson SK, You YN, Buchanan DD, Figueiredo JC, Campbell PT, Gallinger S, Newcomb PA, Potter JD, Lindor NM, Le Marchand L, Haile RW, Hopper JL, Jenkins MA, Basen-Engquist KM, Lynch PM, Pande M (2018). Physical activity and the risk of colorectal cancer in Lynch syndrome. Int J Cancer, 143(9), 2250-2260. (Read full article)
  45. Kocarnik JM, Chun KA, Hardikar S, Robinson J, Berndt SI, Chan AT, Figueiredo JC, Lindor NM, Song M, Schoen RE, Hayes RB, Potter JD, Nassir R, Bezieau S, Le Marchand L, Slattery ML, White E, Peters U, Newcomb PA (2018). Sex-stratified associations of leptin gene variants with colorectal cancer. PLoS One, 13(10).
  46. Citronberg JS, Hardikar S, Phipps A, Figueiredo JC, Newcomb P (2018). Laxative type in relation to colorectal cancer risk. Ann Epidemiol, 28(10), 739-741. (Read full article)
  47. Phipps AI, Shi Q, Zemla TJ, Dotan E, Gill S, Goldberg RM, Hardikar S, Jahagirdar B, Limburg PJ, Newcomb PA, Shields A, Sinicrope FA, Sargent DJ, Alberts SR (2018). Physical Activity and Outcomes in Patients with Stage III Colon Cancer: A Correlative Analysis of Phase III Trial NCCTG N0147 (Alliance). Cancer Epidemiol Biomarkers Prev, 27(6), 696-703. (Read full article)
  48. Hardikar S, Burnett-Hartman AN, Phipps AI, Upton MP, Zhu LC, Newcomb PA (2018). Telomere length differences between colorectal polyp subtypes: a colonoscopy-based case-control study. BMC Cancer, 18(1), 513. (Read full article)
  49. Kocarnik JM, Hua X, Hardikar S, Robinson J, Lindor NM, Win AK, Hopper JL, Figueiredo JC, Potter JD, Campbell PT, Gallinger S, Cotterchio M, Adams SV, Cohen SA, Phipps AI, Newcomb PA (2017). Long-term weight loss after colorectal cancer diagnosis is associated with lower survival: The Colon Cancer Family Registry. Cancer, 123(23), 4701-4708. (Read full article)
  50. Hua X, Phipps AI, Burnett-Hartman AN, Adams SV, Hardikar S, Cohen SA, Kocarnik JM, Ahnen DJ, Lindor NM, Baron JA, Newcomb PA (2017). Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival. J Clin Oncol, 35(24), 2806-2813. (Read full article)
  51. Robinson JR, Newcomb PA, Hardikar S, Cohen SA, Phipps AI (2017). Stage IV colorectal cancer primary site and patterns of distant metastasis. Cancer Epidemiol, 48, 92-95. (Read full article)
  52. Hardikar S, Burnett-Hartman AN, Chubak J, Upton MP, Zhu LC, Potter JD, Newcomb PA (2017). Reproductive factors and risk of colorectal polyps in a colonoscopy-based study in western Washington State. Cancer Causes Control, 28(3), 241-246. (Read full article)
  53. Hardikar S, Johnson LG, Malkki M, Petersdorf EW, Galloway DA, Schwartz SM, Madeleine MM (2015). A population-based case-control study of genetic variation in cytokine genes associated with risk of cervical and vulvar cancers. Gynecol Oncol, 139(1), 90-6. (Read full article)
  54. Hardikar S, Song X, Risques RA, Montine TJ, Duggan C, Blount PL, Reid BJ, Anderson GL, Kratz M, White E, Vaughan TL (2015). Obesity and inflammation markers in relation to leukocyte telomere length in a cross-sectional study of persons with Barrett's esophagus. BMC Obes, 2, 32. (Read full article)
  55. Hardikar S, Newcomb PA, Campbell PT, Win AK, Lindor NM, Buchanan DD, Makar KW, Jenkins MA, Potter JD, Phipps AI (2015). Prediagnostic Physical Activity and Colorectal Cancer Survival: Overall and Stratified by Tumor Characteristics. Cancer Epidemiol Biomarkers Prev, 24(7), 1130-7. (Read full article)
  56. Hardikar S, Onstad L, Song X, Wilson AM, Montine TJ, Kratz M, Anderson GL, Blount PL, Reid BJ, White E, Vaughan TL (2014). Inflammation and oxidative stress markers and esophageal adenocarcinoma incidence in a Barrett's esophagus cohort. Cancer Epidemiol Biomarkers Prev, 23(11), 2393-403. (Read full article)
  57. Hardikar S, Song X, Kratz M, Anderson GL, Blount PL, Reid BJ, Vaughan TL, White E (2014). Intraindividual variability over time in plasma biomarkers of inflammation and effects of long-term storage. Cancer Causes Control, 25(8), 969-76. (Read full article)
  58. Duggan C, Onstad L, Hardikar S, Blount PL, Reid BJ, Vaughan TL (2013). Association between markers of obesity and progression from Barrett's esophagus to esophageal adenocarcinoma. Clin Gastroenterol Hepatol, 11(8), 934-43. (Read full article)
  59. Hardikar S, Onstad L, Blount PL, Odze RD, Reid BJ, Vaughan TL (2013). The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett's esophagus. PLoS One, 8(1), e52192. (Read full article)
  60. Fitzpatrick AL, Kronmal RA, Kimura M, Gardner JP, Psaty BM, Jenny NS, Tracy RP, Hardikar S, Aviv A (2011). Leukocyte telomere length and mortality in the Cardiovascular Health Study. J Gerontol A Biol Sci Med Sci, 66(4), 421-9. (Read full article)
  61. Ferketich AK, Pirie P, Wewers ME, Barquero D, Hardikar S (2008). Women and Tobacco Harm Reduction in Appalachia, Ohio. J Smok Cessat, 3(1), 40-6.
  62. Binkley PF, Lesinski A, Ferguson JP, Hatton PS, Yamokoski L, Hardikar S, Cooke GE, Leier CV (2008). Recovery of normal ventricular function in patients with dilated cardiomyopathy: predictors of an increasingly prevalent clinical event. Am Heart J, 155(1), 69-74. (Read full article)

Conference Proceedings

  1. Hardikar S, Krick B, Benson R, Winn, M, Winterton C, Newcomb PA, Inadomi JM, Ulrich CM (2022). Type-2 diabetes mellitus and risk of colorectal polyps: a colonoscopy-based study using natural language processing. Cancer Epidemiol Biomarkers Prev, 31(7), 1513. 46th Annual Meeting of the American Society of Preventive Oncology, Tucson, AZ.
  2. Burnett-Hartman AN, Hua X, Hardikar S, Kamineni A, Chubak J, Newcomb PA (June 2018). The association between sessile serrated polyps/adenomas and subsequent advanced colorectal neoplasia. Digestive Diseases Week 2018, Chicago, IL.
  3. Hardikar S, Thomas S, Phipps AI, Newcomb PA (March 2018). Differences in leukocyte telomere length, measured using dried blood spot specimens, and survival after colorectal cancer diagnosis. 42nd Annual Meeting of the American society of Preventive Oncology, Tampa, FL.
  4. Kocarnik JM, Hua X, Hardikar S, Robinson J, Newcomb PA (March 2017). Patterns of multivitamin use after colorectal cancer diagnosis in association with long-term survival. 41st Annual Meeting of the American Society of Preventive Oncology, Seattle, WA.
  5. Hardikar S, Onstad L, Blount PL, Reid PJ, Vaughan TL (Oct 2011). Association of systemic markers of chronic inflammation & oxidative stress with esophageal adenocarcinoma in a cohort of Barrett's esophags patients. 10th Annual AACR Conference - Frontiers in Cancer Prevention Research, Boston, MA.

Report

  1. Khan S, Hardikar S, Reeves KW, Wetter DW, Burton-Chase AM (2020). Strategies for Success: Landing Your First Academic Position and Navigating the Early Years-A Report from the American Society of Preventive Oncology's Early Career Investigator Special Interest Group. (1055-9965). United States. (Read full article)

News & Podcasts

Huntsman Cancer Institute News